Dr. Weitao Yao 姚伟涛
Chief Physician
Department of Bone and Soft Tissue Tumors, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of spinal and pelvic tumors. Diagnosis and comprehensive limb-salvage therapy for bone and soft tissue tumors of the extremities.
Dr. Yao holds a medical degree from Third Military Medical University (1996), a PhD in orthopedic surgery from First Military Medical University (2005), and completed postdoctoral training at Shantou University Medical College (2007). Dr. Yao focuses on clinical care and research for bone and soft tissue tumors, has led or participated in over 10 military, provincial, and municipal projects, published over 40 papers, and holds one patent.
Professional roles
- Secretary, Bone and Soft Tissue Tumor Professional Committee, Henan Anti-Cancer Association
- Member, Orthopedics Youth Committee, Henan Medical Association
- Member, Osteoporosis Committee, Henan Medical Association
- Member, Pediatric Orthopedics Group, Henan Medical Association
Name order: in Chinese the family name comes first (Yao Weitao). Papers usually list the name as Weitao Yao or Yao W.
Selected publications
81 papers on PubMed matched by name and affiliation; 48 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int Orthop, 2026 (senior author): Risk factors for postoperative recurrence of sacral chordoma: an eleven-year single-centre retrospective study. PubMed 42860435
- Curr Cancer Drug Targets, 2026 (senior author): Targeting Ferroptosis to Overcome Doxorubicin Resistance in Osteosarcoma: Current Evidence and Future Directions. PubMed 43012285
- Biomedicines, 2026 (senior author): Chemokine-Driven Intercellular Crosstalk in the Osteosarcoma Microenvironment After Neoadjuvant Chemotherapy: A Single-Cell RNA Sequencing Study. PubMed 42792709
- Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 2026 (senior author): [Impact of unplanned surgery on prognosis of myxoid liposarcoma and analysis of salvage treatment strategies]. PubMed 42324194
- Cancers (Basel), 2026 (senior author): Prognostic Analysis of Endoprosthetic Reconstruction Versus Biological Reconstruction in the Treatment of Extremity Osteosarcoma. PubMed 41749863
- ACS Appl Mater Interfaces, 2025 (senior author): Dual-Functional Interface Engineering of Mesoporous Bioactive Glass via Polydopamine Chelation for 3D-Printed Scaffolds with Synergistic Photothermal Therapy and Enhanced Osteogenesis. PubMed 41360715
- Oncol Rev, 2025 (senior author): The role and research progress of the MET signalling pathway in targeted therapy for osteosarcoma. PubMed 40599602
- Curr Treat Options Oncol, 2024 (senior author): Diagnosis and Treatment of Myxoid Liposarcoma. PubMed 39302575
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion